Previous Close | 65.94 |
1-Year Change | -7.47% |
6-Months Change | -11.51% |
3-Months Change | -1.38% |
Moving Avg (50d) | 73.888 |
Moving Avg (200d) | 74.853 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 10.4B |
Beta (3-Years) | 1.13 |
Revenue Growth (ttm) | 4.46% |
Net Profit Margin (ttm) | 13.22% |
Return On Assets (ttm) | 5.92% |
EPS (ttm) | 1 |
PE Ratio (ttm) | 65.94 |
Dividend Yield | 0.73% |
Asset Description: | Bio-Techne Corporation |
Predicted Direction: | Sell |
Signal Strength: | Neutral |
Forecast Date: | 2025-01-24 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
67.259 | 69.237 | 70.556 | 72.534 | 75.831 | 79.128 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Biotechnology |
Country: | United States |
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets. Wikipedia